Novo Nordisk A/S

    NVO ·NYSE ·Pharmaceutical Preparations
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent SEC filings

    • 2026-04-27 6-K Interim Report (Foreign)
    • 2026-04-20 6-K Interim Report (Foreign)
    • 2026-04-20 6-K Interim Report (Foreign)
    • 2026-04-13 6-K Interim Report (Foreign)
    • 2026-04-07 6-K Interim Report (Foreign)
    • 2026-03-30 6-K Interim Report (Foreign)
    • 2026-03-27 6-K Interim Report (Foreign)
    • 2026-03-27 6-K Interim Report (Foreign)
    • 2026-03-26 6-K Interim Report (Foreign)
    • 2026-03-23 6-K Interim Report (Foreign)
    • 2026-03-20 6-K Interim Report (Foreign)
    • 2026-03-17 6-K Interim Report (Foreign)
    • 2026-03-09 6-K Interim Report (Foreign)
    • 2026-03-02 6-K Interim Report (Foreign)
    • 2026-03-02 6-K Interim Report (Foreign)